- Email: [email protected]
Pharmacology & Therapeutics Keyword Index, Volume 89, 2001
Pharmacology & Therapeutics 89 (2001) 311
PHARMACOLOGY & THERAPEUTICS KEYWORD INDEX, VOLUME 89, 2001 AIDS, 17 Antidepressant, 149 Antimalaria drugs, 207 Antioxidants, 187 Apoptosis, 29
Infarct size, 123 Inhibitors, 171 Ischemia, 29, 47, 123
Blood volume, 221
Lysosomes, 139
Calcium, 29, 47, 255 CaM kinase, 149 cAMP-dependent kinase, 149 Cardioprotection, 47 Cardiovascular disease, 187 Circulation, 221 Cirrhosis, 221, 233, 255, 273, 295 Conditioned place preference (CCP), 1
Malaria, 207 Mechanical forces, 273 Mechanisms of resistance, 207 Meconium, 67 Mitochondria, 29 Mode of action, 207 Morphine, 1
Sarcoplasmic reticulum, 47 Sibutramine, 81 Signal transduction, 255 Smooth muscle cells, 273 Sorting, 139 Surfactant, 67 Synaptic plasticity, 149 Synaptotagmin, 149
Newborn, 67 Nitric oxide, 67, 187
Therapy, 17 Transition-state analogs, 171
Obesity, 81 Opinoid peptides, 123 Opinoid receptor, 1 Orlistat, 81 Oxidants, 187 Oxidative stress, 295
UGT, 171
Down-regulation, 139 Drug resistance, 17 Drugs, 171 Endocytosis, 139 Endogenous compounds, 171 Endothelial cells, 273 Energy expenditure, 81 Environmental contaminants, 171 Feeding peptides, 81 Gastrointestinal peptides, 81 G-protein, 139 Heart, 29, 47 HIV, 17 Hyperdynamic, 221
KATP channels, 123
Peroxynitrate, 187 Persistent pulmonary hypertension, 67 Physical dependence, 1 Portal hypertension, 255, 273 Preconditioning, 29, 123 Protein kinase, 123, 149 Psychological dependence, 1
0163-7258/01/$ ± see front matter D 2001 Elsevier Science Inc. All rights reserved. PII: S 0 1 6 3 - 7 2 5 8 ( 0 1 ) 0 0 1 3 4 - 6
Reactive nitroxy species, 295 Reactive oxygen species, 187, 295 Receptor type, 1 Receptors, 139, 233 Review, 67 Ryanodine receptor, 47
Vascular hyporesponsiveness, 255 Vascular reactivity, 221 Vascular smooth muscle, 233, 295 Vascular smooth muscle cells, 255 Vasculopathy, 273 Vasoconstriction, 233 Vasodilatation, 221 Vasorelaxation, 233
PHARMACOLOGY & THERAPEUTICS KEYWORD INDEX, VOLUME 89, 2001 AIDS, 17 Antidepressant, 149 Antimalaria drugs, 207 Antioxidants, 187 Apoptosis, 29
Infarct size, 123 Inhibitors, 171 Ischemia, 29, 47, 123
Blood volume, 221
Lysosomes, 139
Calcium, 29, 47, 255 CaM kinase, 149 cAMP-dependent kinase, 149 Cardioprotection, 47 Cardiovascular disease, 187 Circulation, 221 Cirrhosis, 221, 233, 255, 273, 295 Conditioned place preference (CCP), 1
Malaria, 207 Mechanical forces, 273 Mechanisms of resistance, 207 Meconium, 67 Mitochondria, 29 Mode of action, 207 Morphine, 1
Sarcoplasmic reticulum, 47 Sibutramine, 81 Signal transduction, 255 Smooth muscle cells, 273 Sorting, 139 Surfactant, 67 Synaptic plasticity, 149 Synaptotagmin, 149
Newborn, 67 Nitric oxide, 67, 187
Therapy, 17 Transition-state analogs, 171
Obesity, 81 Opinoid peptides, 123 Opinoid receptor, 1 Orlistat, 81 Oxidants, 187 Oxidative stress, 295
UGT, 171
Down-regulation, 139 Drug resistance, 17 Drugs, 171 Endocytosis, 139 Endogenous compounds, 171 Endothelial cells, 273 Energy expenditure, 81 Environmental contaminants, 171 Feeding peptides, 81 Gastrointestinal peptides, 81 G-protein, 139 Heart, 29, 47 HIV, 17 Hyperdynamic, 221
KATP channels, 123
Peroxynitrate, 187 Persistent pulmonary hypertension, 67 Physical dependence, 1 Portal hypertension, 255, 273 Preconditioning, 29, 123 Protein kinase, 123, 149 Psychological dependence, 1
0163-7258/01/$ ± see front matter D 2001 Elsevier Science Inc. All rights reserved. PII: S 0 1 6 3 - 7 2 5 8 ( 0 1 ) 0 0 1 3 4 - 6
Reactive nitroxy species, 295 Reactive oxygen species, 187, 295 Receptor type, 1 Receptors, 139, 233 Review, 67 Ryanodine receptor, 47
Vascular hyporesponsiveness, 255 Vascular reactivity, 221 Vascular smooth muscle, 233, 295 Vascular smooth muscle cells, 255 Vasculopathy, 273 Vasoconstriction, 233 Vasodilatation, 221 Vasorelaxation, 233